GSP Crop Science Ltd

GSP Crop Science Ltd

₹ 353 -0.93%
25 Mar - close price
About

Company mejorly focusing on fungiside and insecticide and related pesticide

Key Points

Business Profile[1]
The Company is a research-driven agrochemical company with 40+ years of experience since 1985, focused on the development, manufacturing, and distribution of crop protection products across two verticals — Formulations (finished products) and Technicals (active ingredients).

  • Market Cap 1,642 Cr.
  • Current Price 353
  • High / Low 375 / 327
  • Stock P/E 21.7
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 20.9 %
  • ROE 19.6 %
  • Face Value 10.0

Pros

Cons

  • The company has delivered a poor sales growth of 8.68% over past five years.
  • Company has a low return on equity of 11.2% over last 3 years.
  • Dividend payout has been low at 5.39% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
929 1,137 1,521 1,309 1,226 1,409
876 1,043 1,389 1,249 1,125 1,275
Operating Profit 53 94 133 60 101 133
OPM % 6% 8% 9% 5% 8% 9%
13 34 11 6 13 18
Interest 23 18 23 37 34 30
Depreciation 17 18 18 20 19 19
Profit before tax 26 93 102 10 61 102
Tax % 27% 25% 25% 14% 25% 25%
19 70 76 8 46 76
EPS in Rs 64.99 235.99 257.87 29.95 176.91 19.56
Dividend Payout % 8% 4% 4% 7% 6% 4%
Compounded Sales Growth
10 Years: %
5 Years: 9%
3 Years: -3%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: 32%
3 Years: 0%
TTM: 65%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 14%
3 Years: 11%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 29 29 29 27 26 39
Reserves 305 372 446 329 323 383
152 139 320 324 235 246
272 362 453 429 362 483
Total Liabilities 759 903 1,248 1,110 947 1,151
152 153 157 156 165 152
CWIP 7 8 9 15 6 20
Investments 37 0 2 3 8 23
563 742 1,081 936 768 956
Total Assets 759 903 1,248 1,110 947 1,151

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
71 -67 101 172 50
21 -17 -45 17 -48
-50 158 -159 -177 -22
Net Cash Flow 42 73 -103 12 -20

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 111 98 107 124 97 100
Inventory Days 112 128 124 123 97 147
Days Payable 113 135 108 124 102 143
Cash Conversion Cycle 110 90 123 124 91 104
Working Capital Days 45 56 64 55 48 42
ROCE % 22% 19% 6% 15% 21%

Shareholding Pattern

Numbers in percentages

8 Recently
Mar 2026
71.72%
11.85%
5.90%
10.53%
No. of Shareholders 34,072

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents